These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
399 related items for PubMed ID: 31903137
1. NFATc3-dependent expression of miR-153-3p promotes mitochondrial fragmentation in cardiac hypertrophy by impairing mitofusin-1 expression. Wang T, Zhai M, Xu S, Ponnusamy M, Huang Y, Liu CY, Wang M, Shan C, Shan PP, Gao XQ, Wang K, Chen XZ, Liu J, Xie JY, Zhang DY, Zhou LY, Wang K. Theranostics; 2020; 10(2):553-566. PubMed ID: 31903137 [Abstract] [Full Text] [Related]
2. miR-9 and NFATc3 regulate myocardin in cardiac hypertrophy. Wang K, Long B, Zhou J, Li PF. J Biol Chem; 2010 Apr 16; 285(16):11903-12. PubMed ID: 20177053 [Abstract] [Full Text] [Related]
8. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy. Zhao Y, Ponnusamy M, Liu C, Tian J, Dong Y, Gao J, Wang C, Zhang Y, Zhang L, Wang K, Li P. Biochim Biophys Acta Mol Basis Dis; 2017 Nov 01; 1863(11):2871-2881. PubMed ID: 28782654 [Abstract] [Full Text] [Related]
11. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy. Xu X, Su YL, Shi JY, Lu Q, Chen C. Cardiovasc Toxicol; 2021 Sep 01; 21(9):759-771. PubMed ID: 34120306 [Abstract] [Full Text] [Related]
12. Long non-coding RNA CHRF facilitates cardiac hypertrophy through regulating Akt3 via miR-93. Wo Y, Guo J, Li P, Yang H, Wo J. Cardiovasc Pathol; 2018 Sep 01; 35():29-36. PubMed ID: 29747050 [Abstract] [Full Text] [Related]
13. Quercetin Promotes the Repair of Mitochondrial Function in H9c2 Cells Through the miR-92a-3p/Mfn1 Axis. Li F, Li D, Yan X, Zhu F, Tang S, Liu J, Yan J, Chen H. Curr Pharm Biotechnol; 2024 Sep 01; 25(14):1858-1866. PubMed ID: 38173217 [Abstract] [Full Text] [Related]
15. MicroRNA‑1 suppresses cardiac hypertrophy by targeting nuclear factor of activated T cells cytoplasmic 3. Yin H, Zhao L, Zhang S, Zhang Y, Lei S. Mol Med Rep; 2015 Dec 01; 12(6):8282-8. PubMed ID: 26497337 [Abstract] [Full Text] [Related]
16. miR-145-5p targets paxillin to attenuate angiotensin II-induced pathological cardiac hypertrophy via downregulation of Rac 1, pJNK, p-c-Jun, NFATc3, ANP and by Sirt-1 upregulation. Lin KH, Kumar VB, Shanmugam T, Shibu MA, Chen RJ, Kuo CH, Ho TJ, Padma VV, Yeh YL, Huang CY. Mol Cell Biochem; 2021 Sep 01; 476(9):3253-3260. PubMed ID: 33886061 [Abstract] [Full Text] [Related]
18. miR-206 Mediates YAP-Induced Cardiac Hypertrophy and Survival. Yang Y, Del Re DP, Nakano N, Sciarretta S, Zhai P, Park J, Sayed D, Shirakabe A, Matsushima S, Park Y, Tian B, Abdellatif M, Sadoshima J. Circ Res; 2015 Oct 23; 117(10):891-904. PubMed ID: 26333362 [Abstract] [Full Text] [Related]
20. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Liu L, An X, Li Z, Song Y, Li L, Zuo S, Liu N, Yang G, Wang H, Cheng X, Zhang Y, Yang X, Wang J. Cardiovasc Res; 2016 Jul 01; 111(1):56-65. PubMed ID: 27084844 [Abstract] [Full Text] [Related] Page: [Next] [New Search]